Skip to main content

Table 3 Prediction for infection(only patients with Cancer)

From: One-year mortality and Periprosthetic infection rates after Total knee Arthroplasty in Cancer patients: a population-based cohort study

  Adjusted
sHRa(95%C.I.) p-value
Comorbidities
 Myocardial infarct  
 congestive heart failure 1.21 (0.45–3.26) 0.7122
 peripheral vascular 1.58 (0.36–7.02) 0.5493
 cerebrovascular disease 1.65 (0.78–3.48) 0.1866
 dementia 2.81 (0.80–9.85) 0.1060
 chronic lung disease 0.76 (0.37–1.56) 0.4507
 connective tissue disease 1.80 (0.63–5.20) 0.2757
 Ulcer 1.59 (0.81–3.12) 0.1759
 chronic liver disease 1.12 (0.46–2.72) 0.7990
 Diabetes 0.78 (0.33–1.81) 0.5613
 diabetes with end organ damage 1.87 (0.47–7.52) 0.3770
 Hemiplegia 1.92 (0.24–15.21) 0.5363
 moderate or severe kidney disease 0.94 (0.28–3.14) 0.9147
Moderate or severe liver disease
AIDS
 Chemotherapy 1.02 (0.49–2.14) 0.9608
 Metastasis 11.10 (1.22–101.30) 0.0328
  1. sHRa: subdistribution hazard ratio